miR-28-3p Is a Cellular Restriction Factor That Inhibits Human T Cell Leukemia Virus, Type 1 (HTLV-1) Replication and Virus Infection

作者: Xue Tao Bai , Christophe Nicot

DOI: 10.1074/JBC.M114.626325

关键词:

摘要: Human T cell leukemia virus, type 1 (HTLV-1) replication and spread are controlled by different viral cellular factors. Although several anti-HIV microRNAs have been described, such a regulation for HTLV-1 has not reported. In this study, we found that miR-28-3p inhibits virus expression its targeting specific site within the genomic gag/pol mRNA. Because is highly expressed in resting cells, which resistant to infection, investigated potential protective role of against de novo infection. To end, developed new sensitive quantitative assay on basis detection products reverse transcription. We demonstrate does prevent receptor interaction or entry but, instead, induces post-entry block at transcription level. addition, HTLV-1, subtype 1A isolates corresponding Japanese strain ATK-1 present natural, single-nucleotide polymorphism target site. As result polymorphism, sequence was inhibited miR-28. Interestingly, genetic studies transmission shown strain, carries Thr-to-Cys transition mutation, transmitted efficiently between spouses, suggesting miR-28 may play an important transmission.

参考文章(52)
Shigeki Takemoto, Raffaella Trovato, Anna Cereseto, Christophe Nicot, Tatiana Kislyakova, Luca Casareto, Thomas Waldmann, Giuseppe Torelli, Genoveffa Franchini, p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14ARF-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells Blood. ,vol. 95, pp. 3939- 3944 ,(2000) , 10.1182/BLOOD.V95.12.3939
O. Haller, F. Weber, Pathogenic Viruses: Smart Manipulators of the Interferon System Interferon: The 50th Anniversary. ,vol. 316, pp. 315- 334 ,(2007) , 10.1007/978-3-540-71329-6_15
Watanabe, HTLV-1-associated diseases. International Journal of Hematology. ,vol. 66, pp. 257- 278 ,(1997) , 10.1016/S0925-5710(97)00077-7
C Pique, D Pham, T Tursz, M C Dokhélar, Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. Journal of Virology. ,vol. 66, pp. 906- 913 ,(1992) , 10.1128/JVI.66.2.906-913.1992
CR Bangham, Kiran Meekings, Frederic Toulza, Mohamed Nejmeddine, Endre Majorovits, Becca Asquith, Graham P Taylor, The immune control of HTLV-1 infection: selection forces and dynamics Frontiers in Bioscience. ,vol. Volume, pp. 2889- ,(2009) , 10.2741/3420
Aniello Russo, Nicoletta Potenza, Antiviral effects of human microRNAs and conservation of their target sites. FEBS Letters. ,vol. 585, pp. 2551- 2555 ,(2011) , 10.1016/J.FEBSLET.2011.07.015
T. Astier-Gin, J.P. Portail, F. Lafond, B. Guillemain, Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct. Journal of Virological Methods. ,vol. 51, pp. 19- 29 ,(1995) , 10.1016/0166-0934(94)00097-Z
Michael Girardot, Christian Pecquet, Siham Boukour, Laurent Knoops, Augustin Ferrant, William Vainchenker, Stéphane Giraudier, Stefan N. Constantinescu, miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets Blood. ,vol. 116, pp. 437- 445 ,(2010) , 10.1182/BLOOD-2008-06-165985
Marine Malbec, Ferdinand Roesch, Olivier Schwartz, A New Role for the HTLV-1 p8 Protein: Increasing Intercellular Conduits and Viral Cell-to-Cell Transmission Viruses. ,vol. 3, pp. 254- 259 ,(2011) , 10.3390/V3030254